The Microbiology of Hidradenitis Suppurativa
- PMID: 26617355
- DOI: 10.1016/j.det.2015.08.010
The Microbiology of Hidradenitis Suppurativa
Abstract
Although the clinical presentation of Hidradenitis Suppurativa (HS) is strongly reminiscent of bacterial infection, the role of bacteria remains controversial. Studies have isolated an array of different bacterial specimens as well as biofilm formation in lesional HS skin. Consistent findings of Gram-positive cocci and -rods including Staphylococus aureus, Coagulase-negative staphylococci (CoNS) and Corynebacterium species (spp) in deep tissue samples have been demonstrated in HS. Although efficacy of antibiotics, i.e., rifampicin, clindamycin or tetracycline may support a microbial role in disease pathogenesis, the most often isolated bacterial specimens are commensal bacteria (CoNS).
Keywords: Acne inversa; Bacteria; Colonization; Hidradenitis suppurativa; Microbiology.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
The bacteriology of hidradenitis suppurativa: a systematic review.Exp Dermatol. 2015 Oct;24(10):727-31. doi: 10.1111/exd.12793. Epub 2015 Aug 21. Exp Dermatol. 2015. PMID: 26119625
-
Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions.J Eur Acad Dermatol Venereol. 2019 Jan;33(1):170-177. doi: 10.1111/jdv.15183. Epub 2018 Aug 7. J Eur Acad Dermatol Venereol. 2019. PMID: 30022542
-
Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.Dermatol Online J. 2016 Jun 15;22(6):13030/qt85s8s1s8. Dermatol Online J. 2016. PMID: 27617596 Review.
-
Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients.APMIS. 2014 Sep;122(9):804-9. doi: 10.1111/apm.12220. Epub 2014 Jan 30. APMIS. 2014. PMID: 24475943
-
Antibiotic Treatment of Hidradenitis Suppurativa.Dermatol Clin. 2016 Jan;34(1):81-9. doi: 10.1016/j.det.2015.08.013. Dermatol Clin. 2016. PMID: 26617361 Review.
Cited by
-
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.Br J Dermatol. 2019 Nov;181(5):967-975. doi: 10.1111/bjd.17919. Epub 2019 Aug 14. Br J Dermatol. 2019. PMID: 30916379 Free PMC article. Clinical Trial.
-
Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis Suppurativa.Vaccines (Basel). 2023 Jan 13;11(1):179. doi: 10.3390/vaccines11010179. Vaccines (Basel). 2023. PMID: 36680023 Free PMC article. Review.
-
Phenotypic and Genotypic Bacterial Virulence and Resistance Profiles in Hidradenitis Suppurativa.Int J Mol Sci. 2025 Apr 9;26(8):3502. doi: 10.3390/ijms26083502. Int J Mol Sci. 2025. PMID: 40331997 Free PMC article.
-
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.Eur J Hosp Pharm. 2022 Nov;29(6):313-318. doi: 10.1136/ejhpharm-2020-002534. Epub 2020 Dec 16. Eur J Hosp Pharm. 2022. PMID: 33328205 Free PMC article.
-
Virulence Gene Expression of Staphylococcus aureus in Human Skin.Front Microbiol. 2021 Jun 11;12:692023. doi: 10.3389/fmicb.2021.692023. eCollection 2021. Front Microbiol. 2021. PMID: 34177874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous